Fulgent Genetics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Fulgent Genetics is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 70.50M	$ 84.69M	$ 67.85M	$ 66.17M	$ 67.70M
Gross Profit	$ 25.23M	$ 39.84M	$ 20.57M	$ 18.81M	$ 12.99M
EBIT	$ -145.45M	$ 6.86M	$ -14.56M	$ -21.25M	$ -39.64M
EBITDA	$ -138.92M	$ 13.28M	$ -8.25M	$ -14.37M	$ -37.63M
Net Income Common Stockholders	$ -128.15M	$ -13.08M	$ -11.23M	$ -15.34M	$ -23.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 97.47M	$ 84.08M	$ 58.35M	$ 66.17M	$ 79.51M
Total Assets	$ 1.24B	$ 1.36B	$ 1.35B	$ 1.38B	$ 1.39B
Total Debt	$ 1.18M	$ 2.89M	$ 4.56M	$ 5.61M	$ 5.64M
Net Debt	$ -96.29M	$ -81.19M	$ -53.79M	$ -60.56M	$ -73.87M
Total Liabilities	$ 102.04M	$ 96.56M	$ 91.25M	$ 107.85M	$ 116.18M
Stockholders Equity	$ 1.14B	$ 1.26B	$ 1.26B	$ 1.26B	$ 1.27B
Cash Flow	-
Free Cash Flow	$ 12.16M	$ 5.34M	$ -2.20M	$ -9.74M	$ 28.66M
Operating Cash Flow	$ 14.93M	$ 10.24M	$ 9.72M	$ -7.91M	$ 33.21M
Investing Cash Flow	$ 24.27M	$ 20.08M	$ -1.10M	$ -4.35M	$ -92.60M
Financing Cash Flow	$ -25.95M	$ -4.47M	$ -16.26M	$ -1.10M	$ -29.59M

Currency in USD

Fulgent Genetics Earnings and Revenue History

Income Statement >

Fulgent Genetics Debt to Assets

Balance Sheet >

Fulgent Genetics Cash Flow

Cash Flow >

Fulgent Genetics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing